Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 4Breast 2Gastrointestinal 1

Conditions

Hereditary Breast and Ovarian Cancer Syndrome 2Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 467Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Salpingo-oophorectomy × Breast × Clear all
NCT02760849 2026-01-07

Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations

M.D. Anderson Cancer Center

Phase NA Active not recruiting
374 enrolled
BreastGynecologic

Hereditary Breast and Ovarian Cancer Syndrome

NCT03294343 2017-12-26

Risk-Reducing Surgeries for Hereditary Ovarian Cancer

Peking Union Medical College Hospital

Phase NA Unknown
600 enrolled
BreastGastrointestinalGynecologic

Colorectal Neoplasms, Hereditary Nonpolyposis, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡